Effects of lipoic acid, caffeic acid and a synthesized lipoyl-caffeic conjugate on human hepatoma cell lines.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 21796075)

Published in Molecules on July 27, 2011

Authors

Eliana Guerriero1, Angela Sorice, Francesca Capone, Susan Costantini, Pasquale Palladino, Marco D'ischia, Giuseppe Castello

Author Affiliations

1: "Pascale Foundation" National Cancer Institute-Cancer Research Center, Mercogliano (AV), Italy.

Articles by these authors

Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res (2005) 2.28

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol (2005) 1.88

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J Clin Oncol (2004) 1.83

Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology (2007) 1.83

Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle (2010) 1.73

Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma. BJU Int (2013) 1.58

Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. J Clin Oncol (2010) 1.45

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res (2006) 1.37

Developmental neurotoxicity of organophosphorous pesticides: fetal and neonatal exposure to chlorpyrifos alters sex-specific behaviors at adulthood in mice. Toxicol Sci (2006) 1.29

Polybrominated diphenyl ethers: neurobehavioral effects following developmental exposure. Neurotoxicology (2003) 1.25

Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis (2008) 1.17

Human melanoma metastases express functional CXCR4. Clin Cancer Res (2006) 1.15

Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J Immunol (2009) 1.14

Molecular modelling of miraculin: Structural analyses and functional hypotheses. Biochem Biophys Res Commun (2007) 1.13

Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology (2010) 1.07

Prognostic value of serum VEGF in melanoma patients: a pilot study. Anticancer Res (2005) 1.06

Differential in vitro neurotoxicity of the flame retardant PBDE-99 and of the PCB Aroclor 1254 in human astrocytoma cells. Toxicol Lett (2004) 1.05

Molecular diagnostics and personalized medicine in oncology: challenges and opportunities. J Cell Biochem (2013) 1.04

Functional and structural aspects of poplar cytosolic and plastidial type a methionine sulfoxide reductases. J Biol Chem (2006) 1.03

Serum cytokine levels in patients with hepatocellular carcinoma. Eur Cytokine Netw (2010) 1.02

Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels. Neurosci Biobehav Rev (2010) 1.01

Human sirt-1: molecular modeling and structure-function relationships of an unordered protein. PLoS One (2008) 1.01

Ligand migration and binding in the dimeric hemoglobin of Scapharca inaequivalvis. Biochemistry (2007) 1.00

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells. Cancer Immunol Immunother (2004) 0.99

Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice. Exp Gerontol (2006) 0.98

Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction. J Clin Oncol (2003) 0.97

Structural and functional similarities between osmotin from Nicotiana tabacum seeds and human adiponectin. PLoS One (2011) 0.97

Early developmental exposure to BDE 99 or Aroclor 1254 affects neurobehavioural profile: interference from the administration route. Neurotoxicology (2005) 0.97

Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy. Eur J Cancer (2006) 0.96

Oxidative stress in Fanconi anaemia: from cells and molecules towards prospects in clinical management. Biol Chem (2012) 0.94

Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. Biogerontology (2006) 0.94

Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. Biochim Biophys Acta (2011) 0.94

Evidence of publication bias in clinical trials of biotherapies for solid tumors. Cancer (2005) 0.94

Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv Exp Med Biol (2012) 0.93

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment. J Transl Med (2010) 0.93

Human Cytokinome: a new challenge for systems biology. Bioinformation (2010) 0.93

Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases. PLoS One (2013) 0.92

CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type. Cancer Immunol Immunother (2007) 0.91

Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis. Eur Cytokine Netw (2010) 0.91

Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection. PLoS One (2012) 0.91

High-level expression and efficient purification of recombinant human long pentraxin PTX3 in Chinese hamster ovary cells. Protein Expr Purif (2006) 0.91

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome. J Transl Med (2012) 0.90

In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotes. Free Radic Res (2005) 0.90

Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment. J Transl Med (2010) 0.88

Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis. J Gastroenterol Hepatol (2007) 0.88

From clinical description, to in vitro and animal studies, and backward to patients: oxidative stress and mitochondrial dysfunction in Fanconi anemia. Free Radic Biol Med (2013) 0.87

A possible predictive marker of progression for hepatocellular carcinoma. Oncol Lett (2011) 0.87

Is serum Interleukin-17 associated with early atherosclerosis in obese patients? J Transl Med (2014) 0.86

The human prion protein alpha2 helix: a thermodynamic study of its conformational preferences. Proteins (2005) 0.86

Soluble interleukin-2 receptor in stage I-III melanoma. Cytokine (2006) 0.85

CytokineDB: a database collecting biological information. Bioinformation (2009) 0.85

Adjuvant treatment of malignant melanoma: where are we? Crit Rev Oncol Hematol (2005) 0.85

Modeling of the bacterial mechanism of methicillin-resistance by a systems biology approach. PLoS One (2009) 0.83

Prolonged perinatal AZT administration and early maternal separation: effects on social and emotional behaviour of periadolescent mice. Pharmacol Biochem Behav (2003) 0.83

New antitumour cyclic astin analogues: synthesis, conformation and bioactivity. J Pept Sci (2004) 0.83

Transient ligand docking sites in Cerebratulus lacteus mini-hemoglobin. Gene (2007) 0.83

Sjøgren's syndrome-associated oxidative stress and mitochondrial dysfunction: prospects for chemoprevention trials. Free Radic Res (2012) 0.83

Bone marrow cell transcripts from Fanconi anaemia patients reveal in vivo alterations in mitochondrial, redox and DNA repair pathways. Eur J Haematol (2013) 0.82

Early behavioural enrichment in the form of handling renders mouse pups unresponsive to anxiolytic drugs and increases NGF levels in the hippocampus. Behav Brain Res (2006) 0.82

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders. J Transl Med (2010) 0.82

Ascorbic acid: its role in immune system and chronic inflammation diseases. Mini Rev Med Chem (2014) 0.82

Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design. Mol Immunol (2009) 0.82

Characterization and kinetics studies of water buffalo (Bubalus bubalis) myoglobin. Comp Biochem Physiol B Biochem Mol Biol (2006) 0.81

A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration. Cell Cycle (2009) 0.81

Evaluation of selenite effects on selenoproteins and cytokinome in human hepatoma cell lines. Molecules (2013) 0.81

Interactomic and pharmacological insights on human sirt-1. Front Pharmacol (2012) 0.81

Structural dynamics of myoglobin: FTIR-TDS study of NO migration and binding. Biochemistry (2007) 0.81

Lauroside B, a megastigmane glycoside from Laurus nobilis (bay laurel) leaves, induces apoptosis in human melanoma cell lines by inhibiting NF-κB activation. J Nat Prod (2010) 0.80

Molecular characterisation and structural analysis of an interferon homologue in sea bass (Dicentrarchus labrax L.). Mol Immunol (2008) 0.80

Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein alpha 2-helical 180-195 segment, and comparison with full-length alpha 2-helix-derived peptides. J Pept Sci (2008) 0.80

A CD4 homologue in sea bass (Dicentrarchus labrax): molecular characterization and structural analysis. Mol Immunol (2008) 0.80

The European Research Infrastructures of the ESFRI Roadmap in Biological and Medical Sciences: status and perspectives. Ann Ist Super Sanita (2014) 0.80

Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients. World J Cardiol (2010) 0.80

The effect of the osmolyte trimethylamine N-oxide on the stability of the prion protein at low pH. Biopolymers (2006) 0.80

Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis. Carcinogenesis (2005) 0.80

Conformational diseases and structure-toxicity relationships: lessons from prion-derived peptides. Curr Protein Pept Sci (2007) 0.79

Effect of salts on the structural behavior of hPrP alpha2-helix-derived analogues: the counterion perspective. J Pept Sci (2006) 0.79

The prion protein: Structural features and related toxic peptides. Chem Biol Drug Des (2006) 0.79

Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach. Cytokine (2013) 0.79

Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9P21. Melanoma Res (2003) 0.79

A holistic approach to study the effects of natural antioxidants on inflammation and liver cancer. Cancer Treat Res (2014) 0.79

Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma. Oncol Rep (2013) 0.78